Publications

Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential

 100
Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential

Tags:

Previous Article

Interplay between mesothelial and immune cells in the tumor microenvironment

Next Article

LSD analogue with potential for treating schizophrenia

Related Posts

Accessing the vasculature in cancer: revising an old hallmark

Accessing the vasculature in cancer: revising an old ha...

 66

Structural basis of μ-opioid receptor targeting by a nanobody antagonist

Structural basis of μ-opioid receptor targeting by a na...

 73

Mesenchymal stromal cell extracellular vesicles as immune modulators and drug carriers in neurodegenerative disorders

Mesenchymal stromal cell extracellular vesicles as immu...

 79